Evidence map›Paper›PMID 40082675›Full record

ArticleNature reviews. Nephrology2025

Lived experience is essential for innovation in biomedical research.

Jonathan Haydak, Jacob Wright, Paula L Croxson, Ilse S Daehn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature reviews. Nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan Haydak *Barbara T. Murphy Division of Nephrology, Samuel Bronfman Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jacob Wright *Barbara T. Murphy Division of Nephrology, Samuel Bronfman Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Paula L CroxsonDepartment of Neuroscience, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ilse S DaehnBarbara T. Murphy Division of Nephrology, Samuel Bronfman Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, USA. ilse.daehn@mssm.edu.ORCID http://orcid.org/0000-0001-9915-5376

Funding

Glomerular Cell-Cell Crosstalk and InjuryR01DK097253 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAEHN, ILSE SOFIA · 2013 to 2025
$7.3M
TRANSforming Bio-medical Research & Academic Faculty through Opportunity, TRaining, & Mentorship (TRANSFORM)R25GM143262 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVIS, ESA M, MURRELL, AUDREY JEANETTE · 2021 to 2025
$2.4M
Genetic risk and molecular characterization of Diabetic Kidney DiseaseR01DK139395 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ilse Sofia Daehn · 2024 to 2026
$1.0M
MERRIT: Multidisciplinary Engineering and Renal Research for Innovation of TechnologyR25DK124917 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AZELOGLU, EVREN U., LIMA, ERIC GEVORK · 2020 to 2024
$696k
NIDDK NIH HHS R01 DK097253NIDDK NIH HHS R01 DK139395NIDDK NIH HHS R25 DK124917NIGMS NIH HHS R25 GM143262
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40082675
PMCPMC12327537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.